Challenges and opportunities for patients with advanced NSCLC
ICON8: Outcome in progression-free survival for weekly-dose paclitaxel in first-line ovarian cancer
Current landscape and future direction in systemic therapy for renal cell carcinoma (RCC)
GAPVAC-101: personalized vaccines for newly-diagnosed glioblastoma
10-year follow-up: the most effective treatment to ProtecT patients with localized prostate cancer?